Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2

BCG is the most efficient adjuvant therapy for high-risk, non-muscle-invasive bladder cancer (NMIBC). Both innate and adaptive immune responses have been implicated in BCG-mediated effects. BCG vaccination can boost innate immune responses via trained immunity (TI), resulting in an increased resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichler, Renate, Diem, Gabriel, Hackl, Hubert, Koutník, Jiří, Mertens, Laura S., D`Andrea, David, Pradere, Benjamin, Soria, Francesco, Mari, Andrea, Laukhtina, Ekaterina, Krajewski, Wojciech, Teoh, Jeremy Yuen-Chun, Del Guidice, Francesco, Moschini, Marco, Thurnher, Martin, Posch, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374029/
https://www.ncbi.nlm.nih.gov/pubmed/37520557
http://dx.doi.org/10.3389/fimmu.2023.1202157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374029/
https://www.ncbi.nlm.nih.gov/pubmed/37520557
http://dx.doi.org/10.3389/fimmu.2023.1202157

Ejemplares similares